Remove 2019 Remove Health Policy Remove Leadership Remove Life Science
article thumbnail

Rebuilding Resilience, Trust, and Health – Deloitte’s Latest on Health Care and Sustainability

Health Populi

Deloitte has been talking about resilience in leadership across all industries, globally, throughout the pandemic. Deloitte’s Global CEO, addressed four key stakeholder groups for resilience and sustainability: our people/workforce, organizations, society, and leadership’s ability to lead. In July 2020, Punit Renjen.

article thumbnail

Social Determinants of Health – My Early Childhood Education and Recent Learnings, Shared at the HealthXL Global Gathering

Health Populi

In the past decade, I’ve been spending a lot of time considering SDoH through a variety of lenses across the health/care ecosystem, including care providers like hospitals, health insurance companies, pharma and life science, retail health care front doors, and non-profits and foundations.

Medicare 149
article thumbnail

The State of the Union for Prescription Drug Prices

Health Populi

voters in 2020 quite like supporting Medicare’s ability to negotiate drug prices with pharmaceutical companies, shown by the October 2019 Kaiser Family Foundation Health Tracking Poll. Last year, IQVIA estimated a median price for new oncologics in 2019 was $149,000. Few issues unite U.S.